𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostate-specific antigen density: The role in benign prostate hyperplasia, prostate intraepithelial neoplasm, organ-confined prostate carcinoma and advanced prostate carcinoma

✍ Scribed by L. I§ikay; Ö. Yaman; M. Bozlu; Y. Z. Müftüoĝlu; O. Göĝü§


Book ID
110553894
Publisher
Springer Netherlands
Year
1995
Tongue
English
Weight
258 KB
Volume
27
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Tissue concentrations of prostate-specif
✍ Thomas G. Pretlow; Theresa P. Pretlow; Bin Yang; Charlotte S. Kaetzel; Carrie M. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 775 KB

## Abstract Prostate‐specific antigen (PSA), as measured in peripheral blood, is currently the most widely used marker for the assessment of tumor burden in the longitudinal study of patients with carcinoma of the prostate (PCA). Studies from other laboratories have led to the conclusion that a giv

Prostate specific antigen density in pat
✍ Mark Nishiya; Gary J. Miller; David H. Lookner; E. David Crawford 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 696 KB

Background. Prostate specific antigen (PSA) does not appear to have the specificity to distinguish between benign prostate hyperplasia and cancer when the PSA is low. PSA density is thought by many to improve the specificity for cancer; however, this theory remains controversial. Methods. The autho

The use of prostate specific antigen den
✍ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr